Enacts provisions relating to insurance coverage for prescription insulin drugs
Referred: Emerging Issues(H)
Email me when HB 3117 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 3117. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill caps patient cost‑sharing for a 30‑day supply of prescription insulin at $30 and forces health plans to calculate that amount after subtracting all rebates they receive. It also shields rebate details as trade secrets and would apply to any health benefit plan beginning Jan. 1, 2027. The measure failed to pass.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 3117
3 free questions a day, no accountHistory
- Referred: Emerging Issues(H)
- Read Second Time (H)
- Introduced and Read First Time (H)
Sponsors
- Stephanie Hein · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 3117 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 3117 freeOr ask your AI assistant about HB 3117 directly:
Add to Claude, ChatGPT or Cursor